Orthopedics

Top Story

Amedica announces second quarter financial results

August 28, 2015

Amedica Corporation recently announced financial results for the second quarter 2015.
Among the highlights of the report was a 37% year-over-year decrease in year-to-date operational cash burn levels, cash and cash equivalent sum of $12.4 million, and net cash use in operational activities in the half-year decreased by $3.1 million from the span in 2014. Amedica also signed an original equipment manufacturer (OME) letter of intent supply agreement with a leading orthopedic device design and manufacturing company, according to a company release.
The company also noted product revenue fell by $1.1 million in the second quarter 2015, 18% of the same span in 2014.
“During this past quarter, we continued to make progress on our strategic initiatives,” B. Sonny Bal, MD, JD, MBA, chairman and chief executive officer of Amedica, stated in the release. “We continue our focus on financial discipline, and I am very pleased with the private label and OEM partner progress we’ve made this past quarter. Despite sales declines since our necessary restructuring in the first half of this year, we remain confident in our strategy of becoming a biomaterials company. With the appropriate changes made, and based on valuable feedback, we anticipate increased adoption of our material going forward.

From OT Europe

4WEB completes first patient-specific implant procedure in Australia

August 28, 2015
4WEB Medical recently announced completion of the company’s first Australian patient-specific segmental bone defect procedure in Brisbane.  Completed in…
Movers and Shakers

Milinazzo appointed to LDR Holdings board of directors

August 28, 2015
LDR Holding Corporation recently announced it has appointed Alan Milinazzo to its board of directors as a Class I director. He will also serve on the board’s…
FDA News

FDA issues draft guidance on nonproprietary naming of biologics, biosimilars

August 27, 2015
The FDA today announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products.According to an FDA blog post by…
ACL reconstruction with meniscal resection may not impact short-term outcomes In the Journals

ACL reconstruction with meniscal resection may not impact short-term outcomes

August 27, 2015
At 2 years postoperatively, results of this study showed ACL reconstruction with meniscal resection did not contribute to patients’ decreased clinical…
More News Headlines »
Feature Article

Femoral Neck Fracture After Arthroscopic Femoroplasty of the Hip

Orthopedics, August 2015, Volume 38 Issue 8
Hip arthroscopy is an increasingly common procedure, particularly for the treatment of femoroacetabular impingement…
More »
Posterior Tibialis Tendon Dysfunction: Overview of Evaluation and Management. June 2015

Posterior Tibialis Tendon Dysfunction: Overview of Evaluation and Management. June 2015

The posterior tibialis is a muscle in the deep posterior compartment of the calf that plays several key roles in the…
More »
Meeting News Coverage Video
VIDEO: Better function, less complications observed after percutaneous Achilles tendon repair vs open techniques

VIDEO: Better function, less complications observed after percutaneous Achilles tendon repair vs open techniques

August 19, 2015
LONG BEACH, Calif. — At the American Orthopaedic Foot & Ankle Society Annual Meeting, Andrew R. Hsu, MD
More »
morganatic-roan
morganatic-roan